Stock
(Reuters) – Drugmaker Biogen (NASDAQ:BIIB) will buy all outstanding shares of Sage Therapeutics that it does not already own for $7.22 apiece, a filing...
Hi, what are you looking for?
(Reuters) – Meta (NASDAQ:META) CEO Mark Zuckerberg met with U.S. President-elect Donald Trump at Mar-a-Lago on Friday, Semafor news website reported, citing a source...
(Reuters) – Drugmaker Biogen (NASDAQ:BIIB) will buy all outstanding shares of Sage Therapeutics that it does not already own for $7.22 apiece, a filing...
WASHINGTON (Reuters) -Taiwan Semiconductor Manufacturing Co has begun producing advanced 4-nanometer chips for U.S. customers in Arizona, Commerce Secretary Gina Raimondo told Reuters, a...
(Reuters) – GE HealthCare (NASDAQ:GEHC) Technologies beat estimates for quarterly profit on Wednesday as strong demand for its medical devices in the U.S. offset...
(Reuters) – Garmin (NYSE:GRMN) raised its full-year profit and revenue forecasts on Wednesday, expecting a slew of launches of wearable products ahead of the...
(Reuters) -Caterpillar said on Wednesday it expects full-year revenue to be slightly lower from its prior forecast as higher borrowing costs and sticky inflation...
Investing.com — Jean Paul Gaultier owner Puig Brands SA (BME:PUIGb) posted a rise in third-quarter revenue, bolstered by strong demand for fragrances despite a...
(Reuters) -Kraft Heinz on Wednesday tempered its annual forecasts for organic sales and profit as repeated price hikes hurt demand for the packaged food...